Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH

Author:

Loomba Rohit1,Noureddin Mazen2,Kowdley Kris V.3,Kohli Anita4,Sheikh Aasim5,Neff Guy6,Bhandari Bal Raj7,Gunn Nadege8,Caldwell Stephen H.9,Goodman Zachary10,Wapinski Ilan11,Resnick Murray11,Beck Andrew H.11,Ding Dora12,Jia Catherine12,Chuang Jen‐Chieh12,Huss Ryan S.12,Chung Chuhan12,Subramanian G. Mani12,Myers Robert P.12,Patel Keyur13,Borg Brian B.14,Ghalib Reem15,Kabler Heidi16,Poulos John17,Younes Ziad18,Elkhashab Magdy19,Hassanein Tarek20,Iyer Rajalakshmi21,Ruane Peter22,Shiffman Mitchell L.23,Strasser Simone24,Wong Vincent Wai‐Sun25ORCID,Alkhouri Naim26ORCID,

Affiliation:

1. NAFLD Research Center University of California at San Diego La Jolla CA

2. Fatty Liver ProgramCedars‐Sinai Medical Center Los Angeles CA

3. Liver Institute Northwest Seattle WA

4. Arizona Liver Health Chandler AZ

5. GI Specialists of Georgia Marietta GA

6. Covenant Research, LLC Sarasota FL

7. Delta Research Partners, LLC Bastrop LA

8. Pinnacle Clinical Research Austin TX

9. University of Virginia Charlottesville VA

10. Inova Fairfax Hospital Falls Church VA

11. PathAI Boston MA

12. Gilead Sciences Inc. Foster City CA

13. University of Toronto Toronto Ontario Canada

14. Southern Therapy and Advanced Research Jackson MS

15. Texas Clinical Research Institute Arlington TX

16. Jubilee Clinical Research Las Vegas NV

17. Cumberland Research Associates Fayetteville NC

18. Gastro One Germantown TN

19. Toronto Liver Centre Toronto Ontario Canada

20. Southern California Research Center Coronado CA

21. Iowa Digestive Disease Center Clive IA

22. Ruane Medical and Liver Health Institute Los Angeles CA

23. Bon Secours Mercy Health Richmond VA

24. Royal Prince Alfred Hospital and The University of Sydney Camperdown New South Wales Australia

25. Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong Hong Kong

26. Texas Liver InstituteUT Health San Antonio San Antonio TX

Publisher

Wiley

Subject

Hepatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3